Thus, the present study aimed to evaluate the association of two FOXA3 polymorphisms with subclinical atherosclerosis (SA) and cardiometabolic parameters in a cohort well-characterized from the clinical, tomographic, and biochemical points of view. The gene discussed is FOXA3; the disease is atherosclerosis.